Arcturus Therapeutics Ltd. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Arcturus Therapeutics Ltd. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $4.60 million as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2019-05-13
- 2019-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $4.60M.
- 2018-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $4.40M.
- 2018-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $4.50M.
- 2017-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $217.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2019-03-31 | $4.60M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $4.40M 10-K · filed 2019-03-18 |
| 2018-09-30 | $4.50M 6-K · filed 2018-11-07 |
| 2017-12-31 | $217.00K 20-F · filed 2018-05-14 |
| 2016-12-31 | $2.02M 20-F · filed 2017-04-28 |
| 2015-12-31 | $1.94M 20-F · filed 2016-03-04 |
| 2014-12-31 | $2.88M 20-F · filed 2015-02-27 |